NYSE:VNE - Veoneer Stock Price, Forecast & News

Veoneer trades on the New York Stock Exchange (NYSE) under the ticker symbol "VNE."

Veoneer Inc (NYSE:VNE) issued its earnings results on Wednesday, October, 23rd. The company reported ($1.20) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($1.34) by $0.14. The firm earned $462 million during the quarter, compared to the consensus estimate of $475.33 million. Veoneer had a negative return on equity of 27.00% and a negative net margin of 26.11%. The business's quarterly revenue was down 12.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.78) earnings per share. View Veoneer's Earnings History.

Veoneer is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Veoneer.

11 Wall Street analysts have issued twelve-month price objectives for Veoneer's stock. Their forecasts range from $18.00 to $43.00. On average, they anticipate Veoneer's stock price to reach $28.29 in the next twelve months. This suggests a possible upside of 83.8% from the stock's current price. View Analyst Price Targets for Veoneer.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veoneer in the last year. There are currently 1 sell rating, 6 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Veoneer.

Headlines about VNE stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Veoneer earned a media sentiment score of -1.6 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Veoneer.

Veoneer saw a increase in short interest in November. As of November 15th, there was short interest totalling 8,550,000 shares, an increase of 5.7% from the October 31st total of 8,090,000 shares. Based on an average trading volume of 659,500 shares, the short-interest ratio is currently 13.0 days. Currently, 7.7% of the shares of the stock are short sold. View Veoneer's Current Options Chain.

Some companies that are related to Veoneer include Gentex (GNTX), Autoliv (ALV), Allison Transmission (ALSN), LCI Industries (LCII), Dana (DAN), Dorman Products (DORM), Adient (ADNT), Meritor (MTOR), Gentherm (THRM), Standard Motor Products (SMP), American Axle & Manufact. (AXL), Delphi Technologies (DLPH), Garrett Motion (GTX), Stoneridge (SRI) and Tenneco (TEN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Veoneer investors own include Canadian Zinc (CZN), Bayer (BAYN), Seeing Machines (SEE), Eyegate Pharmaceuticals (EYEG), Netflix (NFLX), PepsiCo (PEP), Autoliv (ALV), The Coca-Cola (KO), Prudential Financial (PRU) and ESSILOR INTL S/S (ESLOY).

Veoneer's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include DNB Asset Management AS (0.75%), Millennium Management LLC (0.35%), State Street Corp (0.29%), California Public Employees Retirement System (0.19%), State of New Jersey Common Pension Fund D (0.13%) and Gateway Investment Advisers LLC (0.10%). Company insiders that own Veoneer stock include Arthur Blanchford, Jan Carlson, Mathias Hermansson and Mikko S Taipale. View Institutional Ownership Trends for Veoneer.

VNE stock was sold by a variety of institutional investors in the last quarter, including Barclays PLC, DNB Asset Management AS, Voloridge Investment Management LLC, Investor AB, Gateway Investment Advisers LLC, Millennium Management LLC, State Street Corp and Public Employees Retirement System of Ohio. View Insider Buying and Selling for Veoneer.

VNE stock was acquired by a variety of institutional investors in the last quarter, including State of New Jersey Common Pension Fund D, California Public Employees Retirement System, First Trust Advisors LP, Man Group plc, Great West Life Assurance Co. Can, Squarepoint Ops LLC, Virtu Financial LLC and Zurcher Kantonalbank Zurich Cantonalbank. Company insiders that have bought Veoneer stock in the last two years include Arthur Blanchford, Jan Carlson, Mathias Hermansson and Mikko S Taipale. View Insider Buying and Selling for Veoneer.

Shares of VNE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of VNE stock can currently be purchased for approximately $15.39.

Veoneer has a market capitalization of $1.71 billion and generates $2.23 billion in revenue each year. The company earns $-275,000,000.00 in net income (profit) each year or ($3.17) on an earnings per share basis. Veoneer employs 8,600 workers across the globe.View Additional Information About Veoneer.

The official website for Veoneer is http://www.veoneer.com/.

Veoneer's mailing address is KLARABERGSVIADUKTEN 70 SECTION C6 BOX 13089, STOCKHOLM V7, 10302. The company can be reached via phone at 46-8-527-762-00 or via email at [email protected]